Neurocrine Biosciences (NBIX) Technical (Analysis) Reports Neurocrine Biosciences ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Neurocrine Biosciences (NBIX)
Technical Analysis Report for USA stock NBIX Neurocrine Biosciences. Dated: 28 Aug 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock NBIX Neurocrine Biosciences then click here. or read Experts views on Neurocrine Biosciences or Forecast & share price targets of Neurocrine Biosciences
Neurocrine Biosciences Opened at 155.92 and Closed at: 154.06, which is -1.21% of previous session's close. It moved within a range of 153.08 and 156.57
The session was a Bearish session with an average volume of 812900, which is 10.17% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
Support for tomorrow is 151.83 and resistance for tomorrow is 155.32
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 152.57, 151.08 resistance for tomorrow's hourly charts is 156.06, 158.06
10 Day SMA for Neurocrine Biosciences (NBIX) is 154.27 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Neurocrine Biosciences (NBIX) is 157.33 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Neurocrine Biosciences (NBIX) is 166.8 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 157.33 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Neurocrine Biosciences is 147.45 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Neurocrine Biosciences is at 157.33 and 200 DMA is at 147.45, while 50 DMA and 100 DMA are at 166.8 and 157.33 respectively
Neurocrine Biosciences (NBIX) moving average of 20 SMA is at 157.33 and 20 EMA is at 158.21
| Date | Closing Price | 20 SMA | 20 EMA |
| 28 Fri Aug | 154.06 | 157.33 | 158.21 |
| 27 Thu Aug | 155.92 | 157.97 | 158.65 |
| 26 Wed Aug | 156.59 | 159.45 | 158.94 |
| 25 Tue Aug | 153.37 | 160.66 | 159.19 |
| 24 Mon Aug | 153.04 | 162.13 | 159.8 |
| 21 Fri Aug | 152.57 | 163.3 | 160.51 |
Neurocrine Biosciences (NBIX) moving average of 50 SMA is at 166.8 and 50 EMA is at 161.38
| Date | Closing Price | 50 SMA | 50 EMA |
| 28 Fri Aug | 154.06 | 166.8 | 161.38 |
| 27 Thu Aug | 155.92 | 166.88 | 161.68 |
| 26 Wed Aug | 156.59 | 166.94 | 161.91 |
| 25 Tue Aug | 153.37 | 166.94 | 162.13 |
| 24 Mon Aug | 153.04 | 167.06 | 162.49 |
| 21 Fri Aug | 152.57 | 167.2 | 162.88 |
Neurocrine Biosciences (NBIX) moving average of 100 SMA is at 157.33 and 100 EMA is at 157.68
| Date | Closing Price | 100 SMA | 100 EMA |
| 28 Fri Aug | 154.06 | 157.33 | 157.68 |
| 27 Thu Aug | 155.92 | 157.1 | 157.75 |
| 26 Wed Aug | 156.59 | 156.87 | 157.79 |
| 25 Tue Aug | 153.37 | 156.62 | 157.81 |
| 24 Mon Aug | 153.04 | 156.41 | 157.9 |
| 21 Fri Aug | 152.57 | 156.19 | 158 |
Neurocrine Biosciences (NBIX) moving average of 200 SMA is at 147.45 and 200 EMA is at 149.78
| Date | Closing Price | 200 SMA | 200 EMA |
| 28 Fri Aug | 154.06 | 147.45 | 149.78 |
| 27 Thu Aug | 155.92 | 147.42 | 149.74 |
| 26 Wed Aug | 156.59 | 147.39 | 149.68 |
| 25 Tue Aug | 153.37 | 147.37 | 149.61 |
| 24 Mon Aug | 153.04 | 147.38 | 149.57 |
| 21 Fri Aug | 152.57 | 147.38 | 149.53 |
Laboratory Corporation has performed better than Neurocrine Biosciences in short term. You could have earned much better returns by investing in Laboratory Corporation, about 16.33% more returns!
Glaukos Corporation has performed better than Neurocrine Biosciences in short term. You could have earned much better returns by investing in Glaukos Corporation, about 12.59% more returns!
Encompass Health has performed better than Neurocrine Biosciences in short term. You could have earned much better returns by investing in Encompass Health, about 14.77% more returns!
Xenon Pharmaceuticals has performed better than Neurocrine Biosciences in short term. You could have earned much better returns by investing in Xenon Pharmaceuticals, about 3.67% more returns!
Supernus Pharmaceuticals has performed better than Neurocrine Biosciences in short term. You could have earned much better returns by investing in Supernus Pharmaceuticals, about 2.39% more returns!
Scholar Rock has performed better than Neurocrine Biosciences in short term. You could have earned much better returns by investing in Scholar Rock, about 33.38% more returns!
Ultragenyx Pharmaceutical has performed better than Neurocrine Biosciences in short term. You could have earned much better returns by investing in Ultragenyx Pharmaceutical, about 9.68% more returns!
Oramed Pharmaceuticals has performed better than Neurocrine Biosciences in short term. You could have earned much better returns by investing in Oramed Pharmaceuticals, about 21.9% more returns!
Ironwood Pharmaceuticals has performed better than Neurocrine Biosciences in short term. You could have earned much better returns by investing in Ironwood Pharmaceuticals, about 0.76% more returns!
Hutchison China has performed better than Neurocrine Biosciences in short term. You could have earned much better returns by investing in Hutchison China, about 14.51% more returns!
Eton Pharmaceuticals has performed better than Neurocrine Biosciences in short term. You could have earned much better returns by investing in Eton Pharmaceuticals, about 39.75% more returns!
Cooper Companies has performed better than Neurocrine Biosciences in short term. You could have earned much better returns by investing in Cooper Companies, about 3.2% more returns!
Biolife Solutions has performed better than Neurocrine Biosciences in short term. You could have earned much better returns by investing in Biolife Solutions, about 20.48% more returns!
Argenx Se has performed better than Neurocrine Biosciences in short term. You could have earned much better returns by investing in Argenx Se, about 30.48% more returns!
Alnylam Pharmaceuticals has performed better than Neurocrine Biosciences in short term. You could have earned much better returns by investing in Alnylam Pharmaceuticals, about 14.93% more returns!
Aldeyra Therapeutics has performed better than Neurocrine Biosciences in short term. You could have earned much better returns by investing in Aldeyra Therapeutics, about 4.71% more returns!
Neurocrine Biosciences Technical analysis of indicators
Price action analysis of Neurocrine Biosciences (NBIX) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
ADX buy sell signal for Neurocrine Biosciences stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Neurocrine Biosciences in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Neurocrine Biosciences Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Neurocrine Biosciences in short term but SELL signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Neurocrine Biosciences is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 154.24 and Neurocrine Biosciences NBIX stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Neurocrine Biosciences NBIX stock. Volume based technical analysis of Neurocrine Biosciences NBIX stock is negative.
Neurocrine Biosciences Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock NBIX Neurocrine Biosciences These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And NBIX Experts View which covers a lot of information including buying and selling signals
NBIX future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Neurocrine Biosciences or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Neurocrine Biosciences (NBIX) Technical (Analysis) Reports Neurocrine Biosciences ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance


